![]() |
NEW YORK, July 24, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.
NYSE Content Advisory: Pre-Market update + McGraw Hill, Accelerant IPO on NYSE jwplayer(‘myplayer1’).setup(file: ‘https://mma.prnasia.com/media2/2737653/NYSE_Market_Update_July_24.mp4’, image: ‘https://mma.prnasia.com/media2/2737653/NYSE_Market_Update_July_24.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’);
Ashley Mastronardi delivers the pre-market update on July 24th
- Stocks are mixed Thursday morning following the S&P 500’s 12th record close of the year on Wednesday. The index received a boost Tuesday night when President Trump announced a trade deal with Japan.
- The NYSE was in attendance at the All In’s AI Summit and before President Trump gave his closing keynote, spoke to leaders on a cross-section of topics including AI, energy, robotics, infrastructure, and legislation
- Education solutions firm McGraw Hill, which raised nearly $415 million in its IPO will debut on the NYSE today. Specialty risk company Accelerant, which raised over $723 million, will debut as well.
- The New York Stock Exchange announced this morning that NYSE Texas has listed its first exchange traded funds, with Strive Asset Management dual-listing 13 ETFs
Opening Bell
McGraw Hill celebrates its IPO on the New York Stock Exchange
Closing Bell
The Autism Science Foundation and Wall Street Rides FAR celebrate the 11th season of Rides FAR and its support for innovative autism research.
Click here to download the NYSE TV App
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’

